Home

Headache

Depression, Schizophrenia

Professor Mark Opler - Teaming up with patients

Read time: 3 min

Congress highlights

From probiotics to psychobiotics: nutrition, gut and brain

The weight of microbes in our gut is about the same as the weight of our brain. Almost certainly...

Parkinson's Disease

Read time: 3 min

Congress highlights

Getting rid of alpha-synuclein – active and passive immunotherapy, or maybe targeting LRRK2?

Immunotherapy is an established treatment option for many forms of cancer, and recently received...

Read time: 5 min

Satellite symposium

Can increased focus on patient perspectives improve outcomes in the treatment of schizophrenia?

Discordance between the treatment goals of patients and their clinicians is important, can lead to...

Parkinson's Disease

Read time: 3 min

Congress highlights

Managing strategies for Parkinson’s disease: A multipronged approach for a multifaceted illness

Parkinson’s disease is characterized by motor symptoms and a wide range of non-motor symptoms...

Read time: 4 min

Congress highlights

Functional recovery in depression: are we doing the right thing for the treatment of depression?

Major depressive disorder (MDD) is a heterogeneous disease characterized by many different mood,...

Parkinson's Disease

Read time: 4 min

Congress highlights

Non-motor symptoms – influencing ‘ON’ and ‘OFF’ in Parkinson’s disease

A broad spectrum of non-motor symptoms is highly prevalent in Parkinson’s disease (PD) which...

Professor James MacCabe defines Treatment Resistance Schizophrenia

Depression, Schizophrenia

Read time: 4 min

Congress highlights

Towards new treatment options for MDD and schizophrenia: a role for D2 receptor partial agonists

Major depressive disorder (MDD) and schizophrenia share in common the side effect burden associated...

Depression, Schizophrenia

What are you doing to celebrate World Mental Health Day?

We asked advocacy groups from all around the world why it is important to support World Mental...

Read time: 3 min

Congress highlights

A “syndemic” relationship: Managing depression and diabetes

There is a high level of major depression among people with diabetes, and people with major...

Read time: 4 min

Congress highlights

Do we have enough psychiatry training in medical education? A Global Perspective

Psychiatric disorders comprise a global public health priority as standalone conditions and are...

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind

You are leaving Progress in Mind

Continue to

Cancel

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intented for health care professionals.

All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline

Congress

Register for access to Progress in Mind in your country